Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.
Current GLP-1 drugs for diabetes and obesity management often require frequent injections due to their short half-life. In just two weeks, IPA's LENS ai generated, developed and optimized novel ...
We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
GlobalData on MSN1d
KeyMed partners with US-based biotech Prolium in bispecific antibody dealInvestment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new ...
News Medical on MSN1d
New imaging protocol enhances visualization of rare bone marrow cellsBone marrow plays a crucial role in maintaining hematopoietic stem cells and bone homeostasis. However, research has been ...
From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...
Nano-sized, tumor-targeting particles induced self-destruction of cancer cells in preclinical studies. A new twist on a ...
In a recent study, scientists have introduced an innovative imaging technique that provides an unparalleled view of the bone ...
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study. The experimental approach, which uses tiny capsules called small ...
In return for these rights, ArriVent will pay Lepu a one-time down payment and near-term milestone payments amounting to ...
In a recent study, scientists have introduced an innovative imaging technique that provides an unparalleled view of the bone marrow's intricate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback